AQR Capital Management »

Corbus Pharmaceuticals Hldgs shares owned by AQR Capital Management

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3M 64k 20.63

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ge Aerospace Com New (GE)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Zoom Video Communications In Cl A (ZM)
Cigna Corp (CI)
At&t (T)
Progressive Corporation (PGR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for AQR Capital Management

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
Octagon Capital Advisors
OrbiMed Advisors
BlackRock
BlackRock
Ikarian Capital
Tang Capital Management
Vanguard Group
State Street Corporation
T. Rowe Price Associates
Susquehanna International
Morgan Stanley
Geode Capital Management
Sio Capital Management
Schonfeld Strategic Advisors

View all funds holding Corbus Pharmaceuticals Hldgs